- Incidence and risk factors of acute renal failure after transcatheter arterial chemoembolization for hepatocellular carcinoma
-
Jang BK, Lee SH, Chung WJ, Park KS, Cho KB, Hwang JS, Kim YH, Choi JS, Kwon JH
- KMID: 760781
- Korean J Hepatol.
- 2008 Jun;14(2):168-177.
- doi: 10.3350/kjhep.2008.14.2.168
BACKGROUND/AIMS: Transcatheter arterial chemoembolization (TACE) is a major modality in the treatment of unresectable hepatocellular carcinoma. Acute renal failure (ARF) may occur after TACE because of underlying liver cirrhosis... -
- CITED
-
- Close
- SHARE
-
- Close
